Real-world clinical and economic outcomes of nonobstructive hypertrophic cardiomyopathy: a german claims data analysis. admin8. November 2025
Population estimates of obstructive and non-obstructive hypertrophic cardiomyopathy in the UK and Germany. admin8. November 2025
Clinical and economic burden of hypertrophic obstructive cardiomyopathy in Germany. admin8. November 2025
Assessing the alignment of obstructive hypertrophic cardiomyopathy pharmacological treatments with ESC guidelines in Germany. admin8. November 2025
